XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Follow-on Public Offering
Common Stock
Follow-on Public Offering
Additional Paid-in Capital
Follow-on Public Offering
At The Market Offering
Common Stock
At The Market Offering
Additional Paid-in Capital
At The Market Offering
Equity Line Financing
Common Stock
Equity Line Financing
Additional Paid-in Capital
Equity Line Financing
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Gain
Total
Beginning Balances at Dec. 31, 2022                   $ 29 $ 155,820 $ (115,401) $ (199) $ 40,249
Beginning Balances (in shares) at Dec. 31, 2022                   28,991,548        
Shareholders' Equity                            
Issuance of common stock         $ 197 $ 197   $ 318 $ 318          
Issuance of common stock (in shares)       95,823     189,856              
Equity-based compensation                     1,187     1,187
Other comprehensive gain                         4 4
Net loss                       (6,172)   (6,172)
Ending Balances at Mar. 31, 2023                   $ 29 157,522 (121,573) (195) 35,783
Ending Balances (in shares) at Mar. 31, 2023                   29,277,227        
Beginning Balances at Dec. 31, 2022                   $ 29 155,820 (115,401) (199) $ 40,249
Beginning Balances (in shares) at Dec. 31, 2022                   28,991,548        
Shareholders' Equity                            
Exercise of common stock options (in shares)                           0
Net loss                           $ (17,647)
Ending Balances at Sep. 30, 2023                   $ 30 162,140 (133,048) (196) 28,926
Ending Balances (in shares) at Sep. 30, 2023                   30,417,082        
Beginning Balances at Dec. 31, 2022                   $ 29 155,820 (115,401) (199) 40,249
Beginning Balances (in shares) at Dec. 31, 2022                   28,991,548        
Shareholders' Equity                            
Net loss                           (25,788)
Ending Balances at Dec. 31, 2023                   $ 32 165,826 (141,189) (195) 24,474
Ending Balances (in shares) at Dec. 31, 2023                   32,165,478        
Beginning Balances at Mar. 31, 2023                   $ 29 157,522 (121,573) (195) 35,783
Beginning Balances (in shares) at Mar. 31, 2023                   29,277,227        
Shareholders' Equity                            
Issuance of common stock       $ 1 2,304 2,305                
Issuance of common stock (in shares)       1,009,355                    
Equity-based compensation                     1,025     1,025
Other comprehensive gain                         (1) (1)
Net loss                       (4,726)   (4,726)
Ending Balances at Jun. 30, 2023                   $ 30 160,851 (126,299) (196) $ 34,386
Ending Balances (in shares) at Jun. 30, 2023                   30,286,582        
Shareholders' Equity                            
Issuance of common stock         8 8   $ 210 $ 210          
Issuance of common stock (in shares)       5,500     125,000              
Exercise of common stock options (in shares)                           0
Equity-based compensation                     1,071     $ 1,071
Net loss                       (6,749)   (6,749)
Ending Balances at Sep. 30, 2023                   $ 30 162,140 (133,048) (196) 28,926
Ending Balances (in shares) at Sep. 30, 2023                   30,417,082        
Beginning Balances at Dec. 31, 2023                   $ 32 165,826 (141,189) (195) 24,474
Beginning Balances (in shares) at Dec. 31, 2023                   32,165,478        
Shareholders' Equity                            
Issuance of common stock $ 8 $ 11,888 $ 11,896   381 381                
Issuance of common stock (in shares) 7,557,142     191,273                    
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes                     (106)     (106)
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes (in shares)                   71,973        
Equity-based compensation                     1,171     1,171
Reclassification adjustment of foreign currency translation included in net loss for liquidation of subsidiary                         195 195
Net loss                       (9,151)   (9,151)
Ending Balances at Mar. 31, 2024                   $ 40 179,160 (150,340)   28,860
Ending Balances (in shares) at Mar. 31, 2024                   39,985,866        
Beginning Balances at Dec. 31, 2023                   $ 32 165,826 (141,189) $ (195) $ 24,474
Beginning Balances (in shares) at Dec. 31, 2023                   32,165,478        
Shareholders' Equity                            
Exercise of common stock options (in shares)                           93,350
Net loss                           $ (26,129)
Ending Balances at Sep. 30, 2024                   $ 41 181,759 (167,318)   14,482
Ending Balances (in shares) at Sep. 30, 2024                   40,806,092        
Beginning Balances at Mar. 31, 2024                   $ 40 179,160 (150,340)   28,860
Beginning Balances (in shares) at Mar. 31, 2024                   39,985,866        
Shareholders' Equity                            
Exercise of common stock options                     65     65
Exercise of common stock options (in shares)                   73,350        
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes                     (22)     (22)
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes (in shares)                   53,052        
Equity-based compensation                     1,147     1,147
Net loss                       (7,041)   (7,041)
Ending Balances at Jun. 30, 2024                   $ 40 180,350 (157,381)   23,009
Ending Balances (in shares) at Jun. 30, 2024                   40,112,268        
Shareholders' Equity                            
Issuance of common stock       $ 1 $ 496 $ 497                
Issuance of common stock (in shares)       673,131                    
Exercise of common stock options                     17     $ 17
Exercise of common stock options (in shares)                   20,000       20,000
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes (in shares)                   693        
Equity-based compensation                     896     $ 896
Net loss                       (9,937)   (9,937)
Ending Balances at Sep. 30, 2024                   $ 41 $ 181,759 $ (167,318)   $ 14,482
Ending Balances (in shares) at Sep. 30, 2024                   40,806,092